JB
J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM.NS · NSE
₹2,416.10 +0.30% (+₹7.20)
Market Cap ₹387.9B
P/E Ratio 54.68x
Div. Yield -
ROE 18.67%
Bulios Fair Price
₹1,746
27.7% downside
Current Price
₹2,416
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JBCHEPHARM.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
3 /100
Expensive P/E 54.68x
EV/EBITDA 33.92x
PEG 3.04x
Growth
93 /100
Growing EPS growth 18.60%
Rev. growth 16.79%
Book val. growth 17.17%
Profitability
82 /100
Strong Gross margin 62.75%
Net margin 17.10%
FCF margin 7.61%
Quality
84 /100
Excellent ROIC 15.72%
ROE 18.67%
Asset turnover 0.83x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.92x
Net debt/EBITDA -0.09x
Stability
85 /100
Stable Beta -0.02x
Rev. volatility 9.97%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JBCHEPHARM.NS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Suresh Amin
Employees
5,311
Headquarters
Mumbai
Upcoming events
05 NOV
Earnings
Upcoming earnings report